Feasibility and safety of hydrogen gas inhalation for post-cardiac arrest syndrome-first-in-human pilot study

Tomoyoshi Tamura, Kei Hayashida, Motoaki Sano, Masaru Suzuki, Takayuki Shibusawa, Joe Yoshizawa, Yosuke Kobayashi, Takeshi Suzuki, Shigeo Ohta, Hiroshi Morisaki, Keiichi Fukuda, Shingo Hori

研究成果: Article査読

33 被引用数 (Scopus)

抄録

Background: Hydrogen gas inhalation (HI) ameliorates cerebral and cardiac dysfunction in animal models of postcardiac arrest syndrome (PCAS). HI for human patients with PCAS has never been studied. Methods and Results: Between January 2014 and January 2015, 21 of 107 patients with out-of-hospital cardiac arrest achieved spontaneous return of circulation. After excluding 16 patients with specific criteria, 5 patients underwent HI together with target temperature management (TTM). No undesirable effects attributable to HI were observed and 4 patients survived 90 days with a favorable neurological outcome. Conclusions: HI in combination with TTM is a feasible therapy for patients with PCAS.

本文言語English
ページ(範囲)1870-1873
ページ数4
ジャーナルCirculation Journal
80
8
DOI
出版ステータスPublished - 2016

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

フィンガープリント 「Feasibility and safety of hydrogen gas inhalation for post-cardiac arrest syndrome-first-in-human pilot study」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル